McKesson Canada’s Polygenis committed to ‘positive and lasting impact’
He championed a new model for delivering innovative, patient-centric specialized therapies that helped redefine Canadian care
He championed a new model for delivering innovative, patient-centric specialized therapies that helped redefine Canadian care
Radioligand therapy represents a breakthrough in nuclear medicine,